Search results
Results from the WOW.Com Content Network
This same review reported a global combined prevalence of ADHD of 10% in boys and 5% in girls. [58] While the male-to-female ratio of ADHD diagnoses in childhood is about 2.3:1 in children, it approaches 1.5:1 or lower in adulthood. [15] [9] This is consistent with research revealing underdiagnosis of ADHD in females during childhood. [9]
Improvements in ADHD symptoms in children were significantly greater for dexmethylphenidate XR versus placebo. [6] It also showed greater efficacy than osmotic controlled-release oral delivery system methylphenidate over the first half of the laboratory classroom day but assessments late in the day favoured OROS methylphenidate. [6]
Attention deficit hyperactivity disorder (ADHD) [1] is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and developmentally-inappropriate. [9]
Angela Carpenter Gildner, 55, is a social worker in Washington, D.C. When her son was diagnosed with ADHD, she suspected that she also had the condition and was later diagnosed with it.
Viloxazine is indicated to treat attention deficit hyperactivity disorder (ADHD) in children age 6 to 12 years, adolescents age 13 to 17 years, and adults. [1]Analyses of clinical trial data suggest that viloxazine produces moderate reductions in symptoms; it is about as effective as atomoxetine and methylphenidate but with fewer side effects.
For depression, escitalopram is normally prescribed at a dosage of 10mg to 20mg, taken one time per day. For generalized anxiety disorder and other anxiety disorders, escitalopram is prescribed ...
Attention deficit hyperactivity disorder predominantly inattentive (ADHD-PI or ADHD-I), [3] is one of the three presentations of attention deficit hyperactivity disorder (ADHD). [4] In 1987–1994, there were no subtypes or presentations and thus it was not distinguished from hyperactive ADHD in the Diagnostic and Statistical Manual (DSM-III-R).
At the same time, research showed that something similar was needed. One alternative concept was attention-deficit hyperactivity disorder (ADHD). Gillberg proposed another alternative: DAMP. Gillberg's concept was formulated in the early 1980s, and the term itself was introduced in a paper that Gillberg published in 1986 (see Gillberg [1986]).